Research presented at CHEST 2021 examined how expanded USPSTF lung cancer screening criteria would affect minorities and women.

Sleep apnea research presented at CHEST 2021 examined links between PAP therapy adherence and the prevalence and severity of excessive daytime sleepiness.

Is long-term oxygen therapy needed by most patients after hospitalization for COVID-19?

Pooled data from the LEAP 1 and 2 trials were used to study the efficacy and safety of lefamulin in patients with CABP at risk for severe pneumonia.

An analysis of the CHRONICLE study of severe, uncontrolled asthma showed biologics decreased exacerbations in patient subgroups not previously included in RCTs.

Is there a clinical correlation between patient outcomes for COVID-19 and the use and dosage of acetaminophen?

Is asthma triple therapy with umeclidinium plus fluticasone furoate/vilanterol effective for patients with uncontrolled asthma who overuse SABA as rescue therapy?

Which therapy more effectively reduces severe COPD exacerbations: once-daily FF/UMEC/VI or twice-daily ICS/LABA?

Research presented at CHEST 2021 used machine learning to develop an algorithm for predicting poor response to initial PAH therapy, based on claims data.

To what extent can a home-based, software-driven COPD management program led by respiratory therapists affect hospital admissions?

Study investigators aimed to develop a voice-based early warning system for COPD.

Research presented at CHEST 2021 examines use of a single anesthesia episode for robotic navigational bronchoscopy and pulmonary resection for lung nodules.

To what extent does hospital fluid culture influence the mortality rates of patients with severe sepsis and septic shock?

An analysis of NAVIGATOR trial data on tezepelumab use assessed patient-reported outcomes related to asthma control, symptoms, and HRQoL.

To address the void in data on ventilation trends among children with asthma, investigators analyzed data from the largest US all-payer database.

With cannabis use on the rise, what do we know about patients with asthma who use cannabis?

Research presented at CHEST 2021 assessed an alternative approach to predicting COPD exacerbations during the COVID-19 pandemic.

Researchers evaluated the relationship between e-cigarettes and obstructive pulmonary diseases, taking into account age, gender, ethnicity, and body mass index.

A NYC hospital study explored disease severity in Black individuals with COVID-19 pneumonia, using D-dimer as a surrogate marker.

A post-hoc analysis of the VENTURE trial evaluated whether baseline oral corticosteroid dosage affected the efficacy of dupilumab in improving severe asthma outcomes.

NAVIGATOR trial results presented at CHEST 2021 show the effect of tezepelumab on peak expiratory flow rates in severe asthma.

Researchers conducted pooled analysis of the COUGH-1 and COUGH-2 phase 3 trials of gefapixant for treating refractory/unexplained chronic cough.

Researchers conducted subgroup analysis of revenfenacin phase 3 trial data to assess health status improvements in women vs men with moderate to severe COPD.

A post-hoc analysis compared lung function changes in the INCREASE and TRIUMPH trials of inhaled treprostinil for PH-ILD and PAH.